Boehringer Ingelheim Competitors and Similar CompaniesClear all
Boehringer Ingelheim's competitors and similar companies include Zoetis, AstraZeneca and GSK.
 Boehringer Ingelheim Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing. |  Zoetis Zoetis (formerly known as Pfizer Animal Health) is an animal health company focusing on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products and services. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. | |
Founding Date | Founding Date 1958 | Founding Date 1952 | Founding Date 1999 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Ingelheim am Rhein, DE HQ Ouled Fayet, DZ Munro, AR Macquarie Park, AU Wien, AT Minsk, BY Bruxelles, BE see more | Locations Parsippany, US HQ Buenos Aires, AR Villa Adelina, AR Silverwater, AU Wien, AT Ottignies Louvain La Neuve, BE Zaventem, BE see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more |
Employees | Employees 1,2338% increase | Employees 14,1002% increase | Employees 94,300 | Employees 68,629 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 82.1 b | Valuation ($) 2.7 b | Valuation ($) 862.5 m |
Financial | ||||
Revenue (est.) | Revenue (est.) €12.7b (FY, 2023) | Revenue (est.) $9.5b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) |
Cost of goods | Cost of goods €4b (FY, 2023) | Cost of goods $2.7b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods £5.6b (FY, 2025) |
Gross profit | Gross profit €8.7b (FY, 2023) | Gross profit $6.8b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit £28.5b (FY, 2025) |
Net income | Net income €5.8b (FY, 2023) | Net income N/A | Net income $10.2b (FY, 2025) | Net income £6.3b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 100 (Q3, 2021) | Countries 130 (FY, 2021) | Countries 92 (FY, 2021) |
Trademarks | Trademarks 5.2 k (Feb, 2024) | Trademarks 8.2 k (FY, 2020) | Trademarks N/A | Trademarks N/A |
For sources of this data, please see the company profile
View Company Profiles
Zoetis
HQ
Parsippany, US
Employees
14,100↑ 2% increase
Zoetis (formerly known as Pfizer Animal Health) is an animal health company focusing on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products and services.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company